Because panobinostat plus bortezomib or carfilzomib synergistically induced caspase-8-mediated post-translational Sp1 degradation in MM cells, we next looked at the effects of bortezomib in combination with panobinostat on HDAC1 expression in MM cells. This evidence concerns the gene CASP8 and Miyoshi myopathy.